DK3287471T3 - Polysaccharid, der er egnet til modulering af immunreaktion - Google Patents

Polysaccharid, der er egnet til modulering af immunreaktion Download PDF

Info

Publication number
DK3287471T3
DK3287471T3 DK17189957.8T DK17189957T DK3287471T3 DK 3287471 T3 DK3287471 T3 DK 3287471T3 DK 17189957 T DK17189957 T DK 17189957T DK 3287471 T3 DK3287471 T3 DK 3287471T3
Authority
DK
Denmark
Prior art keywords
immune response
modulating immune
polysaccharide suitable
polysaccharide
modulating
Prior art date
Application number
DK17189957.8T
Other languages
English (en)
Inventor
Ruud Albers
Jari Helin
Werner Klaffke
Jean Hypolites Koek
Petronella Anna Kreijveld
Jari Natunen
Richardus Paulus Anton Oranje
Erwin Werner Tareilus
Original Assignee
Nutrileads B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrileads B V filed Critical Nutrileads B V
Application granted granted Critical
Publication of DK3287471T3 publication Critical patent/DK3287471T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0045—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Galacturonans, e.g. methyl ester of (alpha-1,4)-linked D-galacturonic acid units, i.e. pectin, or hydrolysis product of methyl ester of alpha-1,4-linked D-galacturonic acid units, i.e. pectinic acid; Derivatives thereof
    • C08B37/0048—Processes of extraction from organic materials
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0045—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Galacturonans, e.g. methyl ester of (alpha-1,4)-linked D-galacturonic acid units, i.e. pectin, or hydrolysis product of methyl ester of alpha-1,4-linked D-galacturonic acid units, i.e. pectinic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK17189957.8T 2009-12-11 2010-11-16 Polysaccharid, der er egnet til modulering af immunreaktion DK3287471T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09178876 2009-12-11
EP10776375A EP2510014A1 (en) 2009-12-11 2010-11-16 Polysaccharide suitable to modulate immune response

Publications (1)

Publication Number Publication Date
DK3287471T3 true DK3287471T3 (da) 2021-01-11

Family

ID=42111328

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17189957.8T DK3287471T3 (da) 2009-12-11 2010-11-16 Polysaccharid, der er egnet til modulering af immunreaktion

Country Status (7)

Country Link
US (3) US9260535B2 (da)
EP (2) EP2510014A1 (da)
CN (1) CN102762597A (da)
DK (1) DK3287471T3 (da)
ES (1) ES2858461T3 (da)
PL (1) PL3287471T3 (da)
WO (1) WO2011069781A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101168381B1 (ko) * 2011-04-25 2012-07-27 주식회사 비티씨 녹차 가수분해물의 면역기능 증강 및 식품 조성물 제조 방법
JP5246387B1 (ja) * 2011-10-20 2013-07-24 不二製油株式会社 水溶性大豆多糖類およびその製造法
CA2868921C (en) * 2012-03-28 2022-03-01 The Research Foundation For The State University Of New York Methods and materials related to nutritional supplement compositions containing a potato polysaccharide preparation
WO2014012755A1 (en) 2012-07-18 2014-01-23 Unilever N.V. An edible product
WO2014021795A1 (en) * 2012-08-01 2014-02-06 Asian Phytoceuticals Public Company Limited Method of administrating a series of compositions for dynamic immune modulation
CN104837528B (zh) * 2012-12-17 2020-03-03 荷兰联合利华有限公司 外用组合物
EP2931376B1 (en) 2012-12-17 2017-07-26 Unilever N.V. Topical composition
EP3046566B1 (en) 2013-09-19 2020-12-02 The Research Foundation for The State University of New York Methods and materials for treating liver steatosis
EP3191110A4 (en) * 2014-08-18 2018-04-18 Pharmagenesis, Inc. Polygalacturonan rhamnogalacturonan1 (pgrg1) composition
EP3273972A4 (en) 2015-03-27 2018-10-31 The Research Foundation for The State University of New York Methods and materials for reducing amyloid beta levels within a mammal
JP6788882B2 (ja) 2016-08-09 2020-11-25 イマジン・グローバル・ケア株式会社 自然免疫活性化作用を有する多糖類及び該多糖類を含有する自然免疫活性化剤又は飲食品
EP3700350B1 (en) * 2017-10-23 2024-04-03 NutriLeads B.V. Method of producing a pectic polysaccharide isolate enriched in rhamnogalacturonan-i
AU2018356377B2 (en) * 2017-10-23 2024-08-08 Nutrileads B.V. Enzymatically hydrolysed pectic polysaccharides for treating or preventing infections
MX395082B (es) * 2017-12-04 2025-03-21 Nutrileads B V Composicion para uso en la prevencion o tratamiento de la salmonelosis
PL3846901T3 (pl) 2018-09-07 2025-09-08 Nutrileads B.V. Prebiotyk do leczenia zaburzeń związanych z zaburzoną kompozycją lub funkcjonalnością mikrobiomu jelitowego
CN113480674B (zh) * 2021-08-19 2022-03-08 中南大学 一种黑茶多糖-ⅰ活性成分及其制备方法和在抗癌中应用
FR3126869A1 (fr) 2021-09-16 2023-03-17 Gozen K. K. Japan Composition pharmaceutique comprenant des métabolites issus de la bactérie Bacillus subtilis Gozen GZN-08 isolée de Camellia sinensis et modulant la réponse immunitaire.
AU2023379925A1 (en) 2022-11-15 2025-06-05 Nutrileads B.V. Prebiotic composition for stabilizing a healthy gut microbiota

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3360899B2 (ja) * 1993-10-08 2003-01-07 日本医薬品工業株式会社 癌予防・治療剤
JPH089226A (ja) 1994-06-15 1996-01-12 Fuji Photo Optical Co Ltd カメラの遠隔操作制御装置
US6794495B1 (en) 1998-10-19 2004-09-21 New Nordic Danmark Aps Composition comprising extensin and, optionally, pectic polysaccharides
US20030159178A1 (en) 2000-02-10 2003-08-21 Peter Ulvskov Method for remodelling cell wall polysaccharide structures in plants
DE10019076A1 (de) 2000-04-06 2001-10-18 Lang Christine Verwendung von Polygalakturoniden als Lebensmittelzusatzstoffe
WO2003082308A1 (en) * 2002-03-29 2003-10-09 Yasuyuki Shirota Drugs including anticancer agents and immunopotentiators and health foods and drinks
JP2004107295A (ja) 2002-09-20 2004-04-08 National Agriculture & Bio-Oriented Research Organization ヒスタミン遊離抑制剤
US20050182037A1 (en) * 2002-10-16 2005-08-18 Alan Fergusson Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof
CA2522088A1 (en) 2003-04-16 2004-11-04 The University Of Mississippi Immunostimulatory agents in botanicals
US7141264B2 (en) * 2003-06-02 2006-11-28 Unilever Bestfoods, North America, Division Of Conopco, Inc. Functional water
AU2007227384A1 (en) 2006-03-23 2007-09-27 Herbalscience Singapore Pte. Ltd. Extracts and methods comprising green tea species
EP2214508A1 (en) 2007-12-07 2010-08-11 Unilever N.V. Edible product having an immunostimulating effect
WO2009080447A1 (en) 2007-12-20 2009-07-02 Unilever Nv Edible product having an immunostimulating effect

Also Published As

Publication number Publication date
US20180339040A1 (en) 2018-11-29
US9260535B2 (en) 2016-02-16
PL3287471T3 (pl) 2021-08-02
CN102762597A (zh) 2012-10-31
US20130064858A1 (en) 2013-03-14
EP2510014A1 (en) 2012-10-17
US20160151485A1 (en) 2016-06-02
ES2858461T3 (es) 2021-09-30
WO2011069781A1 (en) 2011-06-16
US10449249B2 (en) 2019-10-22
EP3287471B1 (en) 2020-12-16
EP3287471A1 (en) 2018-02-28
US10098948B2 (en) 2018-10-16

Similar Documents

Publication Publication Date Title
DK2865387T3 (da) Forberedelse af en immunreaktion
BR112013030885A2 (pt) composição de stevia.
DK2571903T3 (da) Polymerer, der reagerer på stimuli, til oprensning af biomolekyler
BRPI1011134A2 (pt) turbomáquina.
HUE055338T2 (hu) Indolamin-2,3-dioxigenáz-alapú immunterápia
BR112013015581A2 (pt) método, e. sistema
DK2283904T3 (da) Komponentsystem
BR112013015783A2 (pt) autoinjetor.
BRPI1012883A2 (pt) dispositivo intercorporal.
BRPI1007047A2 (pt) Biorrefino irganosolv de cana-de-açúcar inteira.
HRP20150107T1 (xx) Derivati dioksabiciklo[3.2.1]oktan-2,3,4-triola
FR2947376B1 (fr) Sectionneur.
IT1398984B1 (it) Dispositivo blocco-porta perfezionato.
IT1398416B1 (it) Dispositivo elettrovalvolare.
IT1396487B1 (it) Convogliatore.
DK2442870T3 (da) Pyrazinooxazepin-derivater.
BRPI1016192A2 (pt) derivados de soxazol.
BR112012000565A2 (pt) ensaio de vírus.
ES1076487Y (es) Dispositivo de hojas correderas batientes.
ES2388306B1 (es) Dispositivo de aparato domestico.
IT1398964B1 (it) Dispositivo di regolazione di flusso.
IT1399382B1 (it) Dispositivo.
BRPI1011056A2 (pt) composições de polissacarídeos.
BR112015003217A2 (pt) novos derivados de piridina.
IT1394461B1 (it) Dispositivo spollonatore.